Dianthus Therapeutics, Inc. Common Stock (DNTH) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for DNTH. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 8,199,893 | $799M | INCREASED |
| T. Rowe Price | 6,403,402 | $624M | INCREASED |
| BlackRock | 4,123,822 | $402M | INCREASED |
| Wellington Management | 3,229,882 | $315M | INCREASED |
| Vanguard | 3,087,840 | $301M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Edward Carr (CHIEF ACCOUNTING OFFICER) | EXERCISE | 20,000 | $358K | 2026-09-17 |
| Edward Carr (CHIEF ACCOUNTING OFFICER) | SELL | 700 | $73K | 2026-09-17 |
| Edward Carr (CHIEF ACCOUNTING OFFICER) | SELL | 1,100 | $114K | 2026-09-17 |
| Edward Carr (CHIEF ACCOUNTING OFFICER) | SELL | 3,501 | $358K | 2026-09-17 |
| Edward Carr (CHIEF ACCOUNTING OFFICER) | SELL | 6,771 | $686K | 2026-09-17 |
Full institutional holdings, insider history, and congressional trades for Dianthus Therapeutics, Inc. Common Stock on SentiSense.